Cryoport, Inc. Retains KCSA Strategic Communications as U.S. Investor Relations Counsel

March 27, 2014 | By Shelley Callahan

LAKE FOREST, California, March 27, 2014 – Cryoport, Inc. (OTC BB: CYRX), the only end-to-end cryogenic logistics solutions provider, today announced that it has retained KCSA Strategic Communications, a leading New York-based communications firm, to lead the Company's investor relations program.

KCSA intends to deploy a comprehensive investor relations communication campaign designed to increase awareness of Cryoport among the U.S. investment community. Since KCSA’s inception over forty years ago, the firm has developed a strong reputation for its work representing public companies. Todd Fromer, Managing Partner of KCSA, will lead the KCSA team and provide strategic counsel on financial communication matters.

“We are excited to begin working with KCSA in order to create greater investor awareness for Cryoport and the changes made throughout the Company. We have a new management team and an expanded offering of solutions,” said Jerrell Shelton, Cryoport’s Chief Executive Officer. “Our cryogenic logistics solutions for biological materials are poised to transform the way stem cells, cell therapies, tissue, diagnostic materials, embryos and other biologic specimens are transported around the world in a safe, reliable and cost-effective way. With KCSA’s proactive approach to our communications program, we will highlight the growth potential for our business to shareholders and the inherent value of our cold chain logistics solutions as we further penetrate the life sciences market.”

Mr. Fromer stated, “Cryoport has established the only end-to-end, fully validated, cryogenic logistics solution for the life science industry at large.  Through direct sales and a strong global logistics network, Cryoport has capitalized on the rapid, worldwide growth of life science sectors such as biologic drugs, stem cells and animal vaccines. With a world-class management team led by Jerrel Shelton, Cryoport is an exciting turnaround story that investors should become familiar with. We believe KCSA can play an important role in generating awareness among investors as well as the media.”

About Cryoport

Cryoport provides leading edge cryogenic shipping logistics solutions to the life science industries through the combination of purpose-built proprietary technologies, including packaging, information technologies and specialized logistics expertise. Our Cryoport Express® liquid nitrogen dry vapor shippers are validated to maintain a constant -150°C temperature for a 10 plus day dynamic shipment duration, and our Cryoportal™ Logistics Management Platform assists in the management of the entire shipment process, including initial order input, document preparation, customs clearance, courier management, shipment tracking, issue resolution, and delivery. Cryoport’s total turnkey service management approach offers reliability, cost effectiveness, and convenience, while the use of recyclable and reusable components provides a “green” and environmentally friendly solution. For more information visit

About KCSA Strategic Communications

KCSA is a fully integrated communications agency specializing in public relations, investor relations and marketing with expertise in financial and professional services, technology, healthcare, media, energy and public services companies. Since 1969, the firm has demonstrated strategic thinking and program execution that drives results for its clients in the ever-changing communications and digital landscape. The firm’s clients are its best references. For more information, please visit

Investor Contacts:

KCSA Strategic Communications
Todd Fromer /Garth Russell
+ 212-682-6300 /


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, KCSA Strategic Communications, Investor Relations